Race and Outcome in Childhood Acute Lymphoblastic Leukemia

JAMA

Volumn 290, Issue 15, 2003, Pages 2061-2063

  Carroll, William L ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; EDITORIAL; GENOTYPE; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; ACUTE LYMPHOCYTIC LEUKEMIA; ETHNOLOGY; GENETICS; MORTALITY; NOTE; TREATMENT FAILURE;

CHILD; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; PROGNOSIS; TREATMENT FAILURE;

EID: 0142024735     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.15.2061     Document Type: Editorial

References (16)

1. Schrappe M, Camitta B, Pui CH, et al. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia. 2000;14:2193-2194.
2. Gaynon PS, Trigg ME, Heerema NA, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia. Leukemia. 2000;14:2223-2233.
3. Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JC. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA. 2003;290:2008-2014.
4. Pui C-H, Sandlund JT, Pei D, et al. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA. 2003;290:2001-2007.
5. Arico M, Valsecchi MG, Camitta B, et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med. 2000;342:998-1006.
6. Shurtleff SA, Buijs A, Behm FG, et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. 1995;9:1985-1989.
7. Uckun FM, Sensel MG, Sather HN, et al. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies. J Clin Oncol. 1998;16:527-535.
8. Nachman JB, Sather HN, Sensel MG, et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med. 1998;338:1663-1671.
9. Pollock BH, DeBaun MR, Camitta BM, et al. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol. 2000;18:813-823.
10. Bhatia S, Sather HN, Heerema NA, et al. Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood. 2002;100:1957-1964.
11. Liu L, Krailo M, Reaman GH, Bernstein L. Childhood cancer patients' access to cooperative group cancer programs. Cancer. 2003;97:1339-1345.
12. Brawley OW. Population categorization and cancer statistics. Cancer Metastasis Rev. 2003;22:11-19.
13. Gordon NH. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev. 2003;22:55-65.
14. Pui CH, Boyett JM, Rivera GK, et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia. 2000;14:2286-2294.
15. Chen CL, Liu Q, Pui CH, et al. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood. 1997;89: 1701-1707.
16. Davies SM, Robison LL, Buckley JD, et al. Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia. J Clin Oncol. 2001;19:1279-1287.